speedymeds.com Oncology
Two Categories of Cancer Drugs?Sep 03, 2010
In this video blog, Dr. John Marshall muses about cancer drugs that provide a modest benefit for most patients vs those that provide enormous benefit for a few. Should we test them differently?
Prescription Drugs--Me-Too Drugs, 2/7Aug 07, 2011
www.youtube.com www.encognitive.com Angell disputes the industry's reputation as an "engine of innovation," arguing that the top US drug makers spend 2.5 times as much on marketing and administration as they do on research. At least a third of the drugs marketed by industry leaders were discovered by universities or small biotech companies, writes Angell, but they're sold to the public at inflated prices. She cites Taxol, the cancer drug discovered by the National Institutes of Health, but sold by Bristol-Myers Squibb for $20000 a year, reportedly 20 times the manufacturing cost. The company agreed to pay the NIH only 0.5 percent in royalties for the drug. The majority of the new products the industry puts out, says Angell, are "me-too" drugs, which are almost identical to current treatments but "no better than drugs already on the market to treat the same condition." Around 75 percent of new drugs approved by the FDA are me-too drugs. They can be less effective than current drugs, but as long as they're more effective than a placebo, they can get the regulatory green light. http
Cancer Drugs Marked Up for Big ProfitJan 14, 2012
A report about companies who are buying generic cancer drugs to sell them at marked up prices is discussed by Ana Kasparian and Cenk Uygur of The Young Turks. Source: www.rawstory.com Subscribe to The Young Turks: bit.ly The Largest Online New Show in the World. Google+: www.gplus.to Facebook: www.facebook.com Twitter: twitter.com
Dangerous Prescriptions - Are they killing you?Aug 27, 2010
What deadly toxins lurk in your medicine cabinet? This hard-hitting PBS Frontline expose on the FDA and drug industry is must viewing for everyone with diabetes, Aids, breast cancer, prostrate cancer, and any condition treated by drugs. Go to www.hm.wholefoodfarmacy.com for more videos and life-saving information.
Loosening of Medicare Reimbursement for Off-Label Cancer DrugsFeb 11, 2010
In this video blog, Dr. John Marshall urges oncologists to be responsible and consider patient benefit when prescribing costly medications, regardless of looser Medicare reimbursement rules.
Concerns Rise Over Shortages of Prescription DrugsDec 22, 2011
Across the country, doctors and patients are struggling to get their hands on some essential prescription drugs. Betty Ann Bowser reports.
John Stossel - FDA (Fatal Delaying Apparatus)Dec 19, 2011
John Stossel examines the lives lost and the damage done at the hands of the Food and Drug Administration. www.LibertyPen.com
Prescription Drugs--Manipulated Clinical Research, 5/7Jul 11, 2011
www.encognitive.com ONE of Australia's most senior cancer specialists has accused pharmaceutical companies of manipulating some clinical trials of medicines for commercial reasons, including deliberately delaying the release of negative findings and being reluctant to fund research into the toxicity of their drugs. Professor Stephen Clarke, who has conducted clinical trials involving humans for 15 years, agreed to speak publicly for the first time because he said it was essential for governments to fund trials of great public importance rather than leaving critical research solely to drug companies. A number of researchers who spoke to The Age agreed, saying commercial decisions meant the public did not always get the full picture about a drug's usefulness and safety. http
Prescription Drug And Conventional Medicine Alternatives - Micro Frequency GeneratorSep 05, 2011
everywhere.bizland.com If you are looking for alternatives to conventional medicine and surgery for a disorder or disease, the Micro Frequency Generator might be right for you. We have worked one on one with hundreds of people and have seen this device work miracles in their lives. You...
Chapter II: High Dose Opioids for Chronic Non-Cancer PainSep 20, 2011
Primary care physicians are the target audience for this video. The purpose of this video is to encourage responsible opioid prescribing practices.
Provigil priceJan 20, 2012
Provigil price - link to online store drugshost.com Modalert (Modafinil) 200 mg / 100 mg Modalert enhances short-term memory and lets users stay awake for extended periods. Excellent quality of ampakines provigil no prescription price price of provigil 100mg ritalin alertec provigil price...
Generic Drugs Men`s Health Tamsulosin (Flomax), free prescription .flvSep 19, 2011
What is benign prostatic hyperplasia? Benign prostatic hyperplasia (also called BPH) is a condition that affects the prostate gland in men. The prostate is a gland found between the bladder (where urine is stored) and the urethra (the tube urine passes through). As men age, the prostate gland slowly grows bigger (or enlarges). As the prostate gets bigger, it may press on the urethra and cause the flow of urine to be slower and less forceful. "Benign" means the enlargement isn't caused by cancer or infection. "Hyperplasia" means enlargement. What are the symptoms of BPH? Most symptoms of BPH start gradually. One symptom is the need to get up more often at night to urinate. Another symptom is the need to empty the bladder often during the day. Other symptoms include difficulty in starting the urine flow and dribbling after urination ends. The size and strength of the urine stream may decrease. These symptoms can be caused by other things besides BPH. They may be signs of more serious diseases, such as a bladder infection or bladder cancer. Tell your doctor if you have any of these symptoms, so he or she can decide which tests to use to find the possible cause. Flomax is used for: Treating enlarged prostate (benign prostatic hyperplasia; BPH).It may also be used for other conditions as determined by your doctor.Flomax is an alpha-blocker. It works by relaxing muscles in the prostate and bladder, which helps to improve urine flow and reduce symptoms of BPH. How to use Flomax ...
Chapter I: Risk of Addiction, Opioids for Chronic Non-Cancer PainJun 01, 2011
Primary care physicians are the target audience for this video. The purpose of this video is to dispel a myth that leads to inappropriate prescribing.
Voices on Reducing Prescription Drug Shortage: Jay CuetaraJan 19, 2012
Jay Cuetara, a cancer patient and advocate for drug shortage reform, speaks about the President's executive action to reduce prescription drug shortages in America and why it is a step in the right direction.
Advising Medicare Beneficiaries - Medco's 2012 Medicare Prescription Drug Plan Helps Members Get the Most Value from Their Benefits
FRANKLIN LAKES, N.J., Nov. 7, 2011 /PRNewswire/ -- With open enrollment season underway, Medco Health Solutions, Inc. (NYSE: MHS) is providing a team of advisors to help Medicare beneficiaries who enroll in Medco Medicare Prescription Plan® (PDP)* understand some of the crucial changes in the Medicare Part D benefit for the 2012 plan year.
Report: Brand Drug 'Copay Coupons' Raise Health Costs for Employers, Unions, and State Governments by $32 Billion
Promotions Lure Insured Consumers From Generics to More Expensive Brands
WASHINGTON, Nov. 3, 2011 /PRNewswire-USNewswire/ -- Prescription copay coupon marketing programs, which lure insured consumers away from generics and toward more expensive brands, will increase costs by $32 billion over the next decade, according to new research from Visante and released today by the Pharmaceutical Care Management Association (PCMA).
Drug companies now offer "copay coupons" to undermine efforts by employers, unions and state governments to reduce costs by assigning higher consumer copays to expensive drugs and lower copays to more affordable drugs.
Report: Brand Drug 'Copay Coupons' Would Raise Costs by $750 Million for Massachusetts Employers, Unions, and State Employee Health Programs
Promotions Lure Insured Consumers to Switch from Generics to Expensive Brands
WASHINGTON, Nov. 3, 2011 /PRNewswire-USNewswire/ -- If Massachusetts repeals its law banning prescription brand drug "copay coupons," costs for employers, unions and state employee health programs would increase by $750 million over the next decade, according to new research from Visante released today by the Pharmaceutical Care Management Association (PCMA).
Brand drug copay coupons induce insured consumers to choose higher-cost brands (despite higher copays) over generics and other, more affordable brands (despite lower copays.) These promotions target only those with prescription drug coverage, not the poor or uninsured (who don't pay copays). Con ...
- New Jersey Jobs, Pharmacy Choice Endangered by Proposed Express Scripts-Medco Merger
- Boomers, Get Fit!
- Man finds dumpster full of mail | Federal Way crime blotter
- Five Tips for Making the Most of Your Medicare Advantage Plan in 2012
- Area residents signing petitions to fight forced mail-order prescriptions
